To understand the process of Candida biofilm development and the effects of antifungal agents on biofilms, we analyzed real-time data comprising time-lapse images taken at times separated by brief intervals. The growth rate was calculated by measuring the change of biofilm thickness every hour. For the antifungal study, 5-h-old biofilms of Candida albicanswere treated with either micafungin (MCFG) or fluconazole (FLCZ). MCFG began to suppress biofilm growth a fewminutes after the initiation of the treatment, and this effect was maintained over the course of the observation period. In contrast, the suppressive effects of FLCZ on biofilm growth took longer to manifest: biofilms grew in the first 5 h after treatment, and then their growth was ...
Background: Biofilm is known to contribute to the antifungal resistance of Candida yeasts. Aureobasi...
Candida species are responsible for recurrent human infections, mostly in immunocompromised patients...
Biofilm formation is a relevant risk factor for mortality in candidemia. Data about serum-based susc...
Antimycotic perfusion through Candida biofilms was demonstrated by a modification of a simple in vit...
Background: The ability to form biofilm enables Candida spp. to cause catheter-related candidaemia. ...
Candida cells can form biofilms that frequently are sources of infections and are less susceptible t...
We have examined the effect of continuous perfusion with antifungals on Candida albicans biofilms un...
The most common antifungal agents used to treat candidiasis are fluconazole and amphotericin B. As ...
© 2016, Springer Science+Business Media New York.The influence of commonly used in clinical practice...
A variety of manifestations of Candida albicans infections are associated with the formation of biof...
Candida biofilm formation is common during infection and environmental growth. We tested the impacts...
The ability of yeast-like fungi to form biofilms (structurally organized microbial communities) lead...
AbstractObjectiveThe aim of this study was to evaluate whether fluconazole (FLZ) could affect the bi...
Candida biofilms have become an increasingly significant clinical problem for hospital-acquired and ...
Objectives: Biofilm studies have been mostly dedicated to the major human fungal pathogen Candida al...
Background: Biofilm is known to contribute to the antifungal resistance of Candida yeasts. Aureobasi...
Candida species are responsible for recurrent human infections, mostly in immunocompromised patients...
Biofilm formation is a relevant risk factor for mortality in candidemia. Data about serum-based susc...
Antimycotic perfusion through Candida biofilms was demonstrated by a modification of a simple in vit...
Background: The ability to form biofilm enables Candida spp. to cause catheter-related candidaemia. ...
Candida cells can form biofilms that frequently are sources of infections and are less susceptible t...
We have examined the effect of continuous perfusion with antifungals on Candida albicans biofilms un...
The most common antifungal agents used to treat candidiasis are fluconazole and amphotericin B. As ...
© 2016, Springer Science+Business Media New York.The influence of commonly used in clinical practice...
A variety of manifestations of Candida albicans infections are associated with the formation of biof...
Candida biofilm formation is common during infection and environmental growth. We tested the impacts...
The ability of yeast-like fungi to form biofilms (structurally organized microbial communities) lead...
AbstractObjectiveThe aim of this study was to evaluate whether fluconazole (FLZ) could affect the bi...
Candida biofilms have become an increasingly significant clinical problem for hospital-acquired and ...
Objectives: Biofilm studies have been mostly dedicated to the major human fungal pathogen Candida al...
Background: Biofilm is known to contribute to the antifungal resistance of Candida yeasts. Aureobasi...
Candida species are responsible for recurrent human infections, mostly in immunocompromised patients...
Biofilm formation is a relevant risk factor for mortality in candidemia. Data about serum-based susc...